Enanta Pharmaceuticals logo
Enanta Pharmaceuticals ENTA
$ 9.31 2.53%

Quarterly report 2024-Q2
added 08-07-2024

report update icon

Enanta Pharmaceuticals Cash Conversion Cycle 2011-2024 | ENTA

Annual Cash Conversion Cycle Enanta Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
66.7 93 88.5 111 - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
111 66.7 89.9

Quarterly Cash Conversion Cycle Enanta Pharmaceuticals

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
40.5 42.6 42.5 - 88.6 104 83 27.6 89.5 113 84.5 28.1 95.4 125 79.4 90.7 115 109 90.2 91.2 106 105 89.5 91.2 107 93.5 40.4 12.8 129 107 102 91.2 83.8 135 31.2 96.8 120 86.6 46.1 59.7 3.74 1.18 55.5 54.7 44.7 41.3 1.72 51.5 18.8 - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
135 1.18 73.9